UB Paderborn / Katalog / Suche / in CDI

Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

BMC psychiatry, 2018-05, Vol.18 (1), p.157-157, Article 157

2018

Link zum Volltext

Verfügbarkeit prüfen

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

The Lancet (British edition), 2012-08, Vol.380 (9840), p.484-490

2012

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Cytokines in a Repeated Measures Prospective Case Study of Interferon-Induced Depression

Biological psychiatry (1969), 2017, Vol.81 (10), p.S399-S399

2017

Link zum Volltext

Verfügbarkeit prüfen

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

Upsala journal of medical sciences, 2018-03, Vol.123 (1), p.50-56

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

Scandinavian journal of gastroenterology, 2019-08, Vol.54 (8), p.1042-1050

2019

Link zum Volltext

Verfügbarkeit prüfen

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy

Scandinavian journal of gastroenterology, 2018-11, Vol.53 (10-11), p.1347-1353

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Systemic Response of Matrix Metalloproteinases and Their Regulators in Campylobacter and Salmonella Patients

Diagnostics (Basel), 2018-12, Vol.8 (4), p.82

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum pentraxin 3 concentrations in neonates

Upsala journal of medical sciences, 2014-03, Vol.119 (1), p.62-64

2014

Link zum Volltext

Verfügbarkeit prüfen

A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function

British journal of clinical pharmacology, 2006-09, Vol.62 (3), p.297-303

2006

Link zum Volltext

Verfügbarkeit prüfen

A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases

Infection ecology & epidemiology, 2015, Vol.5 (1), p.28224-28224

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden

Harm reduction journal, 2023-06, Vol.20 (1), p.77-77, Article 77

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic resistance in children with urinary diversion is common

Läkartidningen, 2011-11, Vol.108 (46), p.2376-2379

2011

Link zum Volltext

Verfügbarkeit prüfen

Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults

Acta Paediatrica, 2005-09, Vol.94 (9), p.1198-1202

2005

Link zum Volltext

Verfügbarkeit prüfen

Vanligt med antibiotikaresistens hos barn med urinvägsavledning

Läkartidningen, 2011, Vol.108 (46), p.2376

2011

Link zum Volltext

Verfügbarkeit prüfen

A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases

Infection ecology & epidemiology, 2015-01, Vol.5

2015

Link zum Volltext

Verfügbarkeit prüfen

986. Inflammatory Cytokines in a Repeated Measures Prospective Case Study of Interferon-Induced Depression

Biological psychiatry (1969), 2017-05, Vol.81 (10), p.S399-S399

2017

Link zum Volltext

Verfügbarkeit prüfen

Correlations between serum amyloid A protein and C-reactive protein in infectious diseases

Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63 (4), p.267-272

2003

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden

Infectious diseases (London, England), 2015-08, Vol.47 (8), p.555-562

2015

Link zum Volltext

Verfügbarkeit prüfen

Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in very immature newborn infants with nosocomial infections

European journal of pediatrics

Link zum Volltext

Verfügbarkeit prüfen

The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy

Scandinavian journal of infectious diseases, 2009, Vol.41 (9), p.663-671

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of pre-existing Hepatitis C NS3 Q80K variant in Genotype la and NS5A Y93H variant in Genotype 3 for interferon-free treatment combinations with direct antiviral agents (DAAs): Real-life experience from a multicenter study in Sweden and Norway

Hepatology (Baltimore, Md.), 2016, Vol.64 (Suppl. S1), p.1001A

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum amyloid a protein (saa) in healthy and infected individuals

Lannergård, Anders

2005

Link zum Volltext

Verfügbarkeit prüfen

Correlations between serum amyloid A protein and C-reactive protein in infectious diseases: Correlations between SAA and CRP

Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63, p.267

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Laboratory Markers for the Detection of Infections in Open-heart Surgery Patients

Scandinavian journal of infectious diseases, 2003-01, Vol.35 (2), p.121-126

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

Inflammatory Cytokines in a Repeated Measures Prospective Case Study of Interferon-Induced Depression

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy

Enhanced Systemic Response of Matrix Metalloproteinases and Their Regulators in Campylobacter and Salmonella Patients

Serum pentraxin 3 concentrations in neonates

A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function

A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases

Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden

Antibiotic resistance in children with urinary diversion is common

Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults

Vanligt med antibiotikaresistens hos barn med urinvägsavledning

A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases

986. Inflammatory Cytokines in a Repeated Measures Prospective Case Study of Interferon-Induced Depression

Correlations between serum amyloid A protein and C-reactive protein in infectious diseases

Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden

Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in very immature newborn infants with nosocomial infections

The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy

Effect of pre-existing Hepatitis C NS3 Q80K variant in Genotype la and NS5A Y93H variant in Genotype 3 for interferon-free treatment combinations with direct antiviral agents (DAAs): Real-life experience from a multicenter study in Sweden and Norway

Serum amyloid a protein (saa) in healthy and infected individuals

Correlations between serum amyloid A protein and C-reactive protein in infectious diseases: Correlations between SAA and CRP

Evaluation of Laboratory Markers for the Detection of Infections in Open-heart Surgery Patients

Suchergebnisse filtern